CELL SIGNALS INC has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BALMORAL AUSTRALIA PTY LTD, GORCZYNSKI REGINALD M and COGNOSCI INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Japan | 5 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Digital networks | |
#5 | Computer technology | |
#6 | IT methods for management |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Digital information transmission | |
#7 | Data processing systems | |
#8 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Sakuma Sadatoshi | 6 |
#2 | Muramatsu Takashi | 5 |
#3 | Matsui Takashi | 4 |
#4 | Kodama Itsuo | 4 |
#5 | Horiba Mitsuru | 4 |
#6 | Kadomatsu Kenji | 4 |
#7 | Hirota Yasushi | 2 |
#8 | Wang Jinyan | 1 |
#9 | Uno Tsukasa | 1 |
#10 | Osuga Yutaka | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008129851A1 | Nitric oxide synthase activator | |
WO2008059616A1 | Antibody recognizing c-domain of midkine | |
JP2008249618A | External secretion disorder diagnostic reagent | |
JP2007139736A | Method for quantitatively determining midkine in blood | |
JP2006188483A | Treating or preventive composition for myocardiopathy or heart failure | |
JP2007297282A | Influence caused by midkine when endometriosis appear | |
WO2005009427A1 | Curative medicine for allergosis | |
WO2004092992A1 | Health information providing system and health information providing method | |
JP2004329917A | System and method for providing health information |